Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation
from American Journal of Transplantation
Non‐invasive biomarker profiles of acute rejection could impact the management of liver transplant recipients. Peripheral blood was collected following LT for discovery and validation. Blood gene profiling was paired with biopsies showing AR or ADNR as well as stable graft function samples.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063